Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nifty500 Healthcare Index
Nifty500 Healthcare Index Performance
Day's Range
Low
₹21,754.30
High
₹21,878.65
52 Week Range
Low
₹17,164.05
High
₹21,896.15
| Previous Close | ₹21,770.50 |
|---|---|
| Day's Range | ₹21,754.30 - ₹21,878.65 |
| Open | ₹21,820.15 |
| 52 Week Range | ₹17,164.05 - ₹21,896.15 |
| Volume | 4,01,74,196 |
Nifty500 Healthcare Index Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Cipla Ltd. | 1423.50 |  3.50 (0.25%) |
Healthcare |
| Dr. Reddy's Laboratories Ltd. | 1178.00 | 1.00 (0.09%) |
Healthcare |
| Lupin Ltd. | 2171.50 | 13.40 (0.62%) |
Healthcare |
| Torrent Pharmaceuticals Ltd. | 5050.00 | 51.00 (1.02%) |
Healthcare |
| Abbott India Ltd. | 26175.00 |  -175.00 (-0.66%) |
Healthcare |
| Glaxosmithkline Pharmaceuticals Ltd. | 3106.40 | 37.30 (1.22%) |
Healthcare |
| Pfizer Ltd. | 4703.80 | -36.60 (-0.77%) |
Healthcare |
| Apollo Hospitals Enterprise Ltd. | 8838.50 | 38.50 (0.44%) |
Healthcare |
| Ipca Laboratories Ltd. | 1950.30 | -9.50 (-0.48%) |
Healthcare |
| Neuland Laboratories Ltd. | 23205.00 | -291.00 (-1.24%) |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24175.65 | 26373.20 | 22182.55 |
| Nifty IT | 31281.7 | 40301.40 | 25699.10 |
| Nifty Next 50 | 74159.15 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 8782.1 | 10443.40 | 8132.40 |
| Nifty Bank | 57496.3 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 64069.5 | 64450.90 | 52032.85 |
| Nifty 500 | 23528.55 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 18405.8 | 18500.95 | 14804.55 |
| Nifty 100 | 25341.75 | 26975.15 | 22720.45 |
| Nifty FMCG | 46815.0 | 58485.05 | 45334.15 |
Latest News
Acutaas Chemicals informs about press release
Pursuant to Regulation 30 of SEBI Listing Regulations Acutaas Chemicals has informed that it enclosed a copy of Press Release dated August 28, 2026 titled as ‘Acutaas Chemicals’ step-down subsidiary Indichem inaugurates Semiconductor Materials Plant at Gongju, The Republic of Korea’. The Press Release shall also be available on the website of the company at www.acutaas.com.
The above information is a part of company’s filings submitted to BSE.
Biocon informs about company statement
Vijaya Diagnostic Centre informs about change in management
Vijaya Diagnostic Centre has informed about Cessation of Dr. Manjula Anagani as Independent Director on completion of tenure w.e.f 21.08.2026.
The above information is a part of company's filings submitted to BSE.
Aster DM Quality Care informs about SAST
Concord Biotech informs about analyst meet
Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time, Concord Biotech has informed that the officials of the Company will be attending an Investor Conference on 26th August 2026 at 01:00 PM to 03:00 PM (IST) organised by Phillip Capital PCG in Ahmedabad. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of NFT500HEALTH index is ₹21855.9 as of 2026-08-28.
The total volume of NFT500HEALTH index is 40155004.00 as of 2026-08-28.
The percentage change in value of NFT500HEALTH index is 0.39% as of 2026-08-28.
The absolute increase in NFT500HEALTH index value since the previous trading day is ₹85.4 as of 2026-08-28.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
People Also Ask
The Nifty 500 Healthcare Index is a sectoral index that tracks selected healthcare companies from the Nifty 500 universe. It represents listed businesses across healthcare delivery, pharmaceuticals, diagnostics, biotechnology, medical services, and related segments.
Companies are selected from healthcare-sector stocks within the Nifty 500 universe based on NSE Indices' methodology and industry classification. The index is reviewed periodically in accordance with the index maintenance methodology.
The Nifty 500 Healthcare Index is calculated using the free-float market capitalisation method. This approach considers only publicly available shares while assigning weights to eligible healthcare companies within the index.
The Nifty 500 Healthcare Index includes companies from pharmaceuticals, hospitals, diagnostics, biotechnology, healthcare services, medical equipment, and related healthcare businesses listed within the broader Nifty 500 universe.
Yes, hospitals, diagnostics, and pharmaceutical companies may be part of the Nifty 500 Healthcare Index if they meet the index provider’s eligibility rules. The index is designed to capture different areas of India’s healthcare sector.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
